Human subjects research. Pediatric study of ADHD drug draws high-level public review.
Jennifer
J
Couzin
D000293:Adolescent; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D001921:Brain / Q000187:drug effects*; D000697:Central Nervous System Stimulants / Q000494:pharmacology* / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic / Q000941:ethics*; D003913:Dextroamphetamine / Q000494:pharmacology* / Q000627:therapeutic use; D028744:Ethics Committees, Research; D006801:Humans; D008279:Magnetic Resonance Imaging; D008774:Methylphenidate / Q000494:pharmacology; D009316:National Institutes of Health (U.S.); D014481:United States; D014486:United States Food and Drug Administration; D018172:United States Office of Research Integrity
D000697:Central Nervous System Stimulants; D008774:Methylphenidate; D003913:Dextroamphetamine